Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Kisspeptin ELISA Kit (AC3736)
Cat.#: ASET-2325
Specifications
Description Human Kisspeptin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Kisspeptin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.053 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2531 Rat Tyrosine Hydroxylase ELISA Kit (AC3942) Quantitative inquiry ASET-2469 Mouse Npffr2 ELISA Kit (AC3880) Quantitative inquiry ASET-1571 Human VCAM1 ELISA Kit (AC2982) Quantitative inquiry ASET-2289 Rat Dehydroepiandrosterone ELISA Kit (AC3700) Quantitative inquiry ASET-1158 Human MLPH ELISA Kit (AC2569) Quantitative inquiry ASET-2438 Human Netrin 1 ELISA Kit (AC3849) Quantitative inquiry ASET-2219 Mouse RAGE ELISA Kit (AC3630) Quantitative inquiry ASET-1405 Human Thimet Oligopeptidase ELISA Kit (AC2816) Quantitative inquiry ASET-1429 Human PMP22 ELISA Kit (AC2840) Quantitative inquiry ASET-2145 Mouse NRG1 ELISA Kit (AC3556) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket